Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

0.9174 -0.0726 (-7.33%)
Streaming Delayed Price Updated: 11:43 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Hldgs Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Ginkgo Bioworks Shares Gain As Q4 Sales, FY22 Guidance Surpass Street Expectations
Ginkgo Bioworks Holdings Inc (NYSE: DNA) reported  
Via Benzinga
Why Ginkgo Bioworks Stock Is Rising After Hours
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher in Monday's after-hours session after the company reported financial results and issued guidance above estimates.  
Via Benzinga
Earnings Scheduled For March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million. 
Via Benzinga
Ginkgo Bioworks Adds Ultra-High-Throughput Screening Platform Via FGen Acquisition
Ginkgo Bioworks Holdings Inc (NYSE: DNA) has agreed to acquire FGen AG, a Swiss company specializing in strain development and optimization. Under the... 
Via Benzinga
Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities. 
Via Benzinga
23 Stocks That Have Sold Off Hard Since The Russia-Ukraine War Began
The S&P 500 is having a rough start to 2022, down 11.27% year to date. Since Russia invaded Ukraine on Feb. 24, the S&P 500 has fallen an additional 0.78%. Following are... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022
Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth... 
Via Benzinga
7 Stocks to Buy After Sentiment Slipped to Lows
With sentiment souring over inflation and other concerns, contrarians may have an opportunity to bank on certain stocks to buy like these. 
Via InvestorPlace
Did Going Public Give This Company Momentum? Stran & Company Closes First Acquisition; Adds Over $7 Million in Annualized Revenue
Photo by Catkin on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Some... 
Via Benzinga
Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed
Acquisition to enable Ginkgo to bolster its growing biosecurity platform and provide expanded COVID-19 testing options to communities in Massachusetts and beyond BOSTON, Jan. 19,... 
Via Benzinga
Why Ginkgo Bioworks Shares Are Trading Higher Today
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher Wednesday after the company reported preliminary unaudited 2021 revenue highlights and a business review. Ginkgo... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... 
Via Benzinga
Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 32.58% to $4.72 during Friday's regular session. Trading volume for this security as of 12:30 EST is 45.2... 
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share. Celyad Oncology SA (NASDAQ: CYAD) shares jumped 38.7% to... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
58 Biggest Movers From Friday
Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO... 
Via Benzinga
Why Shares of Ginkgo Bioworks Plunged Today
A new project in the Lone Star state wasn't enough to convince the bears to hold on to their shares. 
Via The Motley Fool
32 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (... 
Via Benzinga
Exposures Product Safety
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, gaining 0.55% to 4,511.35. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
52 Biggest Movers From Yesterday
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group... 
Via Benzinga
44 Biggest Movers From Yesterday
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after... 
Via Benzinga
Ginkgo Bioworks Price Predictions: Why One Analyst Thinks Hard-Hit DNA Stock Can Hit $14.50
Today, a bullish analyst price target placed on Ginkgo Bioworks has sent DNA stock on a nice ride as investors pile into this growth play. 
Via InvestorPlace
Why Shares of Gingko Bioworks Are Skyrocketing Today
Wall Street is waxing bullishly on this synbio start-up. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021
Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ: 
Via Benzinga
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader. 
Via The Motley Fool
DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation
Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.